IFC & Insurance Marketing’s Amgen AMGN Stock Holding History

IFC & Insurance Marketing’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-44	Closed	-$14K	–	94
2025 Q4	$14K	Buy	+44	New	+$14K	0.01%	336

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

IFC & Insurance Marketing's AMGN Position: Q1 2026 in Review

IFC & Insurance Marketing sold out of Amgen (AMGN) in Q1 2026, closing a stake of 44 shares — an estimated $14K sold.

IFC & Insurance Marketing first reported a position in AMGN in Q4 2025 and held it in 1 quarter. The position peaked at $14K in Q4 2025. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

IFC & Insurance Marketing reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
IFC & Insurance Marketing sold 44 Amgen shares in Q1 2026, an estimated $14K.
IFC & Insurance Marketing first reported a position in Amgen in Q4 2025 and held it in 1 quarter.
IFC & Insurance Marketing's Amgen position peaked at $14K in Q4 2025.
3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on IFC & Insurance Marketing's 13F filing for Q1 2026, filed 17 Apr 2026.